Steward Partners Investment Advisory »

Celldex Therapeutics shares owned by Steward Partners Investment Advisory

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Steward Partners Investment Advisory from 13F filings

Historical chart of Steward Partners Investment Advisory investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Steward Partners Investment Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Steward Partners Investment Advisory

Quarter filed Position value Share count Share price at filing
2023-12-31 $16k 400 39.66
2023-09-30 $11k 400 27.52
2023-06-30 $14k 400 33.93

More positions owned by Steward Partners Investment Advisory

Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p Mcp Etf (IJH)
UnitedHealth (UNH)
Ishares Tr Rus 1000 Grw Etf (IWF)
Home Depot (HD)
Tesla Motors (TSLA)

View all positions for Steward Partners Investment Advisory

Top funds holding Celldex Therapeutics

Wellington Management Company
Eventide Asset Management
Vanguard Group
Kynam Capital Management
Point72 Asset Management
Bellevue Group
Marshall Wace
Redmile Group
Octagon Capital Advisors
Commodore Capital
Jennison Associates
Charles Schwab Investment Management
5AM Venture Management
Goldman Sachs Group
Sphera Funds Management

View all funds holding Celldex Therapeutics